These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37365720)

  • 1. SARS-CoV-2 vaccination in paediatric patients with epilepsy: experience of a tertiary center in Colombia.
    Ortiz-de la Rosa JS; Ramón-Gómez JL; Martínez-Córdoba N; Lince-Rivera I
    Rev Neurol; 2023 Jul; 77(1):13-18. PubMed ID: 37365720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observational retrospective analysis of vaccination against SARS-CoV-2 and seizures: VACCI-COVID registry.
    Martinez-Fernandez I; Sanchez-Larsen A; Gonzalez-Villar E; Martínez-Martín Á; von Quednow E; Del Valle-Pérez JA; Andrés-López A; Restrepo-Carvajal LC; Cuenca-Juan F; Ballesta-García M; Sopelana D
    Epilepsy Behav; 2022 Sep; 134():108808. PubMed ID: 35809503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of COVID-19 vaccine on epilepsy in adult subjects: an Italian multicentric experience.
    Romozzi M; Rollo E; Quintieri P; Dono F; Evangelista G; Consoli S; Veleno L; Anzellotti F; Calvello C; Costa C; Servidei S; Calabresi P; Vollono C
    Neurol Sci; 2022 Aug; 43(8):4627-4634. PubMed ID: 35501537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccination uptake in children with epilepsy and vaccine hesitancy among their parents: a survey.
    Lou D; Song Y; Li D; Shi Y; Wang B; Yang L
    Eur J Pediatr; 2024 Jun; 183(6):2763-2768. PubMed ID: 38558312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccine take-up rate and safety in adults with epilepsy: Data from a multicenter study in China.
    Lu L; Zhang Q; Xiao J; Zhang Y; Peng W; Han X; Chen S; Yang D; Sander JW; Zhou D; Xiong W
    Epilepsia; 2022 Jan; 63(1):244-251. PubMed ID: 34806164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccination in patients with epilepsy: First experiences in a German tertiary epilepsy center.
    von Wrede R; Pukropski J; Moskau-Hartmann S; Surges R; Baumgartner T
    Epilepsy Behav; 2021 Sep; 122():108160. PubMed ID: 34166950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccine in patients with Dravet syndrome: Observations and real-world experiences.
    Hood V; Berg AT; Knupp KG; Koh S; Laux L; Meskis MA; Zulfiqar-Ali Q; Perry MS; Scheffer IE; Sullivan J; Wirrell E; Andrade DM
    Epilepsia; 2022 Jul; 63(7):1778-1786. PubMed ID: 35383912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccination-related exacerbation of seizures in persons with epilepsy.
    Pang EW; Lawn ND; Chan J; Lee J; Dunne JW
    Epilepsy Behav; 2023 Jan; 138():109024. PubMed ID: 36495798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A postmortem study of patients vaccinated for SARS-CoV-2 in Colombia.
    Chaves JJ; Bonilla JC; Chaves-Cabezas V; Castro A; Polo JF; Mendoza O; Correa-Rodríguez J; Piedrahita AC; Romero-Fandiño IA; Caro MV; González AC; Sánchez LK; Murcia F; Márquez G; Benavides A; Quiroga MDP; López J; Parra-Medina R
    Rev Esp Patol; 2023; 56(1):4-9. PubMed ID: 36599599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of SARS-CoV-2 infection on seizure, anxiety, and depression in 107 patients with epilepsy.
    Zhou S; Zhang D; Chang J; Xia Z; Li J; Ni M; Li H
    Epilepsy Behav; 2023 Aug; 145():109290. PubMed ID: 37406559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmed cases of COVID-19 after vaccination against COVID in health personnel in Bogotá, Colombia.
    Porras-Ramírez A; Sánchez-París R; López-Devia W; Moreno-Perilla Z; Jurado-Zambrano R; Luna-Jaspe Caina C; Sefair C; Ramos N; Otero-Cadena M; Lievano R
    Vaccine; 2023 Sep; 41(41):6072-6076. PubMed ID: 37661532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cryptogenic new-onset super-refractory status epilepticus following SARS-CoV-2 vaccination. A case report].
    Villagrán-Sancho D; Luque-Ambrosiani AC; Mayorga-Morón C; Gómez-Fernández FJ; Arzalluz-Luque J; Castela-Murillo A; Hernández-Ramos FJ; Jiménez-Hernández MD; Palomino-García A
    Rev Neurol; 2023 Jun; 76(12):399-402. PubMed ID: 37303102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study.
    Özdemir HN; Dere B; Gökçay F; Gökçay A
    Neurol Sci; 2022 Jun; 43(6):3489-3496. PubMed ID: 35224704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provoked seizures and status epilepticus in a pediatric population with COVID-19 disease.
    Thongsing A; Eizadkhah D; Fields C; Ballaban-Gil K
    Epilepsia; 2022 Aug; 63(8):e86-e91. PubMed ID: 35532892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccination hesitancy and safety among adult people with epilepsy in eastern China.
    Wang S; Lv J; He C; Yang Y; Zheng Y; Ye L; Chen C; Shen C; Xu S; Ding Y; Guo Y; Tang Y; Wang S; Ding M
    Epilepsy Behav; 2023 Jan; 138():108984. PubMed ID: 36423385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seizures as the main presenting manifestation of acute SARS-CoV-2 infection in children.
    Kurd M; Hashavya S; Benenson S; Gilboa T
    Seizure; 2021 Nov; 92():89-93. PubMed ID: 34481322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.